, More recently, iia antigen associ ated with viral hepatitis, type A. CH.A Ag} has been iden tified and serologic methods developed for its detection (3, 4) , Using these two serologic markers, it;is now possible to positively identify an episode of hepatitis as having been either type A or type H hepatitis, ititeresiugly, such studies have shown that not all eases of viral hepatitis can be attributed to hepatitis A or hepatitis B;virus (J-9). Fur thermore, these non-A, non-B hepatitis cases cannot be accounted for by cytomegalovirus or Epstein-Ban virus infections. These findings suggest that there Is at least a thinJ-h«niaa-hepatitiS"Viru5"lF8iismitted"by"senifii ; "However i ' the infectious nature of non-A, noo-B: hepatitis and its responsible agent have not as yet been shown.
The transmissihiltty of viral hepatitis by means of human serum wast, of course, proved long before the discoveries of HHv\i; $».'• M-\ -\ 8 I-i studies conducted in the early 1950s, sew from several asymptomatic Hood donors, who
• Fmbi Hi e HeraiJiii Branch, Divitton e( Itoocl aid III«id fmnhms. Bureau at BttHagm, Fwd »:u! Drin A<ii»i»lslr»ti«a; soil Us Labui'Moiy of InTectimn Disaw., Marfan*! Iiisllitite wt Altergy smd Infectious Disuucx. Ni.llo.u.1 1 nit ft ii is or Heata; fc*. ' ' ; were suspected of having transmitted hepatitis to trans-& • • ipieiiiSfwere shewn (o be infeetitms-when-inocalated into human volunteers (10-12). The sera from these studies, which were collected 25 years ago, have been stored at 20 "C, The present study was undertaken to reanalyze those transmission studies using mow-recently developed serologic techniques for ihe identification of type A and type B hepatitis.
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Details of ihe utiginnt studies as well as clinical outcomes have been published previously (10, III. These studies exam ined ihe possible infeeiiwty of six asymptomatic btootl donors, each of whom hud been impiicated in ihe transmission of viral hepatitis after a single-unit transfusion. The recipient of each unit of blood from these donors had developed clinically apparent hepatitis 32 to 70 days after transfusion, bin none had received, additional waits of blood or plasma derivatives. The si* "implicated" blood donors were contacted, questioned as to history of hepatitis or liver disease, ejammed for evideuce of hepatic dysfunction, and had blood samples drawn for a battery of liver function tests. Blood samples obtained from these sii donors at a point 43 to 315 days after the initial donation were stored frown at -• 20 X and used for transmission studies.
These transmission studies were carried out as a part of a targe-scale studv on means of inaetivaung bepaiitis virus in blood (12). The recipients of the infectious materials were male inmates of federal penitentiaries who were between the ages of 21 and 4ft and who had volunteered for these studies. Immediately before inoculation and weekly thereafter for m least 6 months, the recipients were questioned as to symptoms of hepatiiis, examined for evidence of liver disease, and had blood drawn for various liver function tests (bilirubin, eepbalin flocculatum, and thymol turbidity I *, Residual serum specimens were stored frozen at 20 "C, The present study is based upon the clinical records and liver-function-test data collected at the time of the original study as well as upon the results of serologic assays recently done on ihe stored serum samples fr P m donors and recipients. Sera were tenet! for HBsAj by radioimmunoassay 113,1 and counterelectrophoresis (14). Subtypini of BltsAf was done on 'Positive "Siiaiplf §""fcf' "immunodiffusion 115') »nd radioimmuno> assay (16!. The hepatiiis 8 ™e" antigen was assayed in selected sera by immunodiffusion (17). Antibody to HlsAg (and-Mls) was tested by passive heniagihiimntion using human erythro cyte* coated wiih HBsAg/adw CIS}, Samples lising eipdsocal results for anti-HBs were assayed bs radioimmunoassay m well (19). Antibody to the hepatitis 1 core antigen (anti-Hic) was assayed in selected serum samples by complement fisa- ' IeCIL^.
, br tween ibe igcs of 22 and 37. None gave a history of hepa-
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inoculated subculaneously into I Table 3 
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found in the inoculum {15« ) ( > ). in a rcinoculation study,. I nuijjj n 11i': Copyright of Annals of Internal Medicine is the property of American College of Physicians and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
